Publication | Closed Access

Vitreous Mediators after Intravitreal Bevacizumab or Triamcinolone Acetonide in Eyes with Proliferative Diabetic Retinopathy

Vitreous MediatorsDiabetic RetinopathyOcular DiseaseProliferative Diabetic RetinopathyVitreous BodyOphthalmologyExperimental OphthalmologyGlaucomaOcular PathologyOcular PharmacologyMedicineIntravitreal Bevacizumab